Drug recall · October 5, 2016
Lamotrigine Tablets recall
Why: Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India; Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662; NDC 29300-113-05.
- Lots / codes
Lot #: GLEH 16003, Exp 03/31/18
- Quantity
- 368 bottles
- Company
- Unichem Pharmaceuticals Usa Inc, Hasbrouck Heights, NJ
- Distribution
- Nationwide
- Initiated
- August 19, 2016 · Voluntary: Firm initiated
- Classified
- September 23, 2016
- Reported
- October 5, 2016
- Ended
- February 7, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lamotrigine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.